CHEMO PHARMA LABORATORIES LTD. - 506365 - Intimation Of Book Closure For Annual General Meeting Of The Company Which Is Going To Be Held On Tuesday, 27Th August, 2019
Intimation of Book Closure for Annual General Meeting of the Company which is going to be held on Tuesday, 27th August, 2019 CHEMO PHARMA LABORATORIES LTD. - 506365 - Submission Of Un-Audited Quarterly Financial Results For The Quarter Ended 30Th June, 2019
Submission of Un-Audited Quarterly Financial Results for the quarter ended 30th June, 2019 CHEMO PHARMA LABORATORIES LTD. - 506365 - Outcome of Board Meeting
We would like to inform you that the Board of Directors in its Meeting held on Thursday, 18th July, 2019 at 04:00 p.m. at the Corporate Office of the Company at 3rd Floor, Empire House, 214, Dr. D. N. Road, Fort, Mumbai - 400001, inter-alia took the following decisions: 1.Considered and approved Un-Audited Financial Results as recommended by the Audit Committee for the quarter ended 30th June, 2019. 2.Placed and taken on record the Limited Review Report issued by the Statutory Auditor on Un-Audited Financial Results for the quarter ended 30th June, 2019. 3.Considered proposed notice received from shareholder of the Company proposing appointment of Shri. Mathura Prasad Sharma as director of Company to be designated as Non-Executive Independent Director of the Company for a term of five consecutive years subject to approval of members of the Company in the forthcoming Annual General Meeting to be held on Tuesday, 27th August, 2019. 4.Considered proposed notice received from shareholder of the Company proposing appointment of Smt. Shanta Somani as director of Company to be designated as Non-Executive Director of the Company subject to approval of members of the Company in the forthcoming Annual General Meeting to be held on Tuesday, 27th August, 2019. 5.Considered proposal of re-appointment of Shri. Balkishan Lohia as director of Company to be designated as Non-Executive Independent Director of the Company for a second term of five consecutive years subject to approval of members of the Company in the forthcoming Annual General Meeting to be held on Tuesday, 27th August, 2019. 6.Consider and... CHEMO PHARMA LABORATORIES LTD. - 506365 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Details of Duplicate Share Certificate issued CHEMO PHARMA LABORATORIES LTD. - 506365 - Shareholding for the Period Ended June 30, 2019
Chemo Pharma Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click here Chemo Pharma Laboratories Ltd - 506365 - Statement Of Investor Complaints For The Quarter Ended June 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Ashok SomaniDesignation :- Director CHEMO PHARMA LABORATORIES LTD. - 506365 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
CERTIFICATE UNDER REGULATION 74 (5) OF THE SECURITIES AND EXCHANGE BOARD OF INDIA (DEPOSITORIES AND PARTICIPANTS) REGULATIONS, 2018 FOR THE QUARTER ENDED 3OTH JUNE, 2019 CHEMO PHARMA LABORATORIES LTD. - 506365 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday, 18Th July, 2019
CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/07/2019 ,inter alia, to consider and approve Intimation of Board Meeting to be held on Thursday, 18th July, 2019 CHEMO PHARMA LABORATORIES LTD. - 506365 - Closure of Trading Window
Closure of Trading Window for all Designated persons covered under the Code of Conduct to regulate, monitor and report trading by Designated Persons from 1st July, 2019 till 48 hours after the announcement of financial results for the quarter ending 30th June, 2019 to the public. CHEMO PHARMA LABORATORIES LTD. - 506365 - Announcement under Regulation 30 (LODR)-Change in Directorate
This is to inform you that pursuant to Regulation 30 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, we wish to inform you following matters- 1. The Board of Directors in its meeting held on Monday, 27th May, 2019 at 04 p.m. at the corporate office of the Company took on record that cessation of Shri. Mathura Prasad Sharma from the position of Directorship in the Category of Non-Executive Independent Director of the Company pursuant to Regulation 1A of Regulation 17 of SEBI (Listing Obligations and Disclosure Requirements) (Amendment) 2018. 2. The Board appointed Shri. Nandkumar Pareek as an Additional Director of the Company in the Category of Non-Executive Independent Director, brief profile of whom is enclosed as Annexure A to the this document. 3. The Board considered resignation of Smt. Shanta Somani from the position of Directorship of the Company.